Published • loading... • Updated
One Study Analyzes the Genetic Variations of Patients with Breast Cancer Who Are More at Risk of Developing a Serious Side Effect From a Drug.
Summary by informacion.es
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
elcorreogallego.es+3 Reposted by 3 other sources
The PROCURE project, a study involving 27 hospitals throughout Spain, has identified genes related to the risk of developing pneumonitis - one of the most serious toxicities caused by inflammation of lung tissue - in patients with breast cancer treated with the innovative drug trastuzumab deruxtecan (T-DXd).
Coverage Details
Total News Sources4
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
